CIK 0001359931
- Non-accelerated filer
- Smaller reporting company
Protara Therapeutics, Inc.
Sign in to watch- Ticker
- TARA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 204580525
- Phone
- +1 646-844-0337
- Business address
- 345 PARK AVENUE SOUTH, 3RD FLOOR, NEW YORK, NY, 10010
- Former names
- Protara Therapeutics, Inc., ArTara Therapeutics, Inc., PROTEON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-01-10 | Bandari Jathin Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +81,000 | 81,000 | ||
| 2022-01-03 | Zummo Jacqueline Chf Scientific Operations Off | Grant or award | +14,100 | 83,560 | ||
| 2022-01-03 | Zummo Jacqueline Chf Scientific Operations Off | Grant or award · Stock Option (Right to Buy) | +84,800 | 84,800 | ||
| 2022-01-03 | Shefferman Jesse CEO and President | Grant or award | +42,300 | 877,505 | ||
| 2022-01-03 | Shefferman Jesse CEO and President | Grant or award · Stock Option (Right to Buy) | +253,500 | 253,500 | ||
| 2022-01-03 | Davis Blaine Chief Financial Officer | Grant or award | +14,100 | 15,581 | ||
| 2022-01-03 | Davis Blaine Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +84,800 | 84,800 | ||
| 2021-12-29 | Opaleye Management Inc. 10% owner | Purchase | +4,500 | $6.98 | $31K | 120,000 |
| 2021-12-28 | Opaleye Management Inc. 10% owner | Purchase | +1,591 | $6.36 | $10K | 2,530,000 |
| 2021-12-28 | Opaleye Management Inc. 10% owner | Purchase | +5,500 | $6.36 | $35K | 115,500 |
| 2021-12-27 | Opaleye Management Inc. 10% owner | Purchase | +31,700 | $6.53 | $207K | 2,528,409 |
| 2021-12-27 | Opaleye Management Inc. 10% owner | Purchase | +5,000 | $6.53 | $33K | 110,000 |
| 2021-12-23 | Opaleye Management Inc. 10% owner | Purchase | +500 | $6.60 | $3K | 2,496,709 |
| 2021-12-23 | Opaleye Management Inc. 10% owner | Purchase | +800 | $6.60 | $5K | 105,000 |
| 2021-12-20 | Opaleye Management Inc. 10% owner | Purchase | +703 | $6.49 | $5K | 2,496,209 |
| 2021-12-17 | Opaleye Management Inc. 10% owner | Purchase | +2,300 | $6.60 | $15K | 2,495,506 |
| 2021-12-17 | Opaleye Management Inc. 10% owner | Purchase | +490 | $6.60 | $3K | 104,200 |
| 2021-12-16 | Opaleye Management Inc. 10% owner | Purchase | +6,500 | $6.41 | $42K | 2,493,206 |
| 2021-12-16 | Opaleye Management Inc. 10% owner | Purchase | +1,063 | $6.41 | $7K | 103,710 |
| 2021-11-18 | Opaleye Management Inc. 10% owner | Purchase | +14,206 | $6.98 | $99K | 2,486,706 |
Page 11 of 17 · 335 trades